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Summary The development and characterisation of a new epithelial model for the experimental investigation
of metastasis is described. A tissue culture cell line CMT64 was established from a spontaneous alveolar lung
carcinoma of a 17 month old female C57BL/ICRF a' mouse (Franks et al., 1976). Subcutaneous inoculation
ofcells produces local tumours which give rise to a small number of lung metastases within three weeks. Four
different tissue culture sublines CMT167, 170, 175 and 181 with increased metastatic ability were selected
from pooled lung metastases by culture, mouse inoculation and reselection from lung metastases through four
culture/inoculation cycles. These sublines are themselves heterogeneous and clones derived from them display
marked differences in metastatic behaviour. Both CMT64 and its sublines have remained relatively stable in
morphology and behavior since their origin, are fairly well differentiated, produce basal lamina even in
metastases, and metastasise rapidly and preferentially to the lung after subcutaneous and intravenous
inoculation in both syngeneic C57 and Nu/Nu mice (Franks & Layton, 1984). The expression of the
metastatic potential of these cells is strongly influenced by the age and immune status of the host. The
CMT64 system is a particularly useful model for experimental metastasis studies.
Many, if not all, tumours are comprised of cell
subpopulations which are heterogeneous in the
expression of many characters, including the ability
to metastasise (for reviews see Poste & Fidler, 1980;
Talmadge, 1983). Most naturally occurring tumours
are epithelial, but many experimental systems for
metastasis studies are derived from non-epithelial
tumours, or even if epithelial have often been
induced by irradiation, chemicals or viruses.
Induced tumours often express a level of
immunogenicity rarely found with spontaneous
tumours (Hewitt, 1976; Poste, 1982).
We report here the development and
characterisation of a new animal model for
metastasis based on the lung tumour cell line
CMT64 (Franks et al., 1976). This epithelial cell
line derived from a spontaneous alveologenic
carcinoma of a female C57BL/ICRF a' mouse has
remained relatively stable in morphology and
behaviour since its origin and although fairly well
differentiated, metastasises rapidly to the lung in
both syngeneic C57B/T and Nu/Nu female mice.
Materials and methods
Mice
Specific pathogen free C57BL/Icrf at (C57B/T) mice
(Rowlatt et al., 1969) and athymic female Nu/Nu
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mice of mixed genetic background were bred at the
Imperial Cancer Research Fund laboratories
(ICRF). Adult female C57B/T mice (4-6 months
old) were used in all experiments unless otherwise
stated.
Cell culture methods
Cells were grown on tissue culture grade plastic
dishes ('Nunclon' - Hospital and Laboratory
Supplies, Ilford, Essex); in EClO medium:
Dulbecco's modified Eagle's medium (E4) without
antibiotics, supplemented with 10% newborn calf
serum, 1% penicillin/streptomycin - 1OOunitsml-1;
(Penicillin/Streptomycin solution 10,000unitsml-1;
Gibco Europe Ltd., Renfrewshire, Scotland) and
1% kanamycin sulphate-100pgml - (Kanamycin
sulphate 750pgmg-1; Sigma London Chemical Co.
Ltd., Dorset, England) and incubated at 37°C in a
humidified atmosphere of 10% CO2 in air. Cultures
at confluence were resuspended with 0.06%
trypsin/1 mM diaminoethanetetra-acetic acid and
passaged at 1:10 split. Viability of cells was shown
by trypan blue dye exclusion to be >95%. Culture
medium was replaced every 3 days and cells
passaged every 6-7 days. Cell lines were regularly
tested and shown to be free of mycoplasma
contamination using the Hoescht fluorochrome
method of Chen (Chen, 1977). Explant cultures
were established by seeding healthy mixed tumour
fragments at low density in tissue culture dishes in
EClO medium.
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Tumour transplantation and cell inoculation
The lower right flank was used in all experiments
as the subcutaneous (s.c.) site for tumour
transplants and cell inoculation. Tumours were
transplanted by the implantation of pooled tumour
fragments from different non-necrotic areas of
tumour (to exclude any selective artefact due to
structural zonal heterogeneity (Trope, 1982; Fidler
& Hart, 1981)) using a Bashford needle.
Suspensions of viable single cells (cell number
assessed by duplicate aliquot counts using a Coulter
counter and viability by trypan blue dye exclusion)
were injected in 0.1 ml of serum and antibiotic-free
E4.
Quantitation ofpulmonary metastases
Surface pulmonary metastases visualized by
distending the bronchi with India ink (for details
see Wexler, 1966) appeared as discrete white
patches against black healthy lung tissue and were
counted on separated lung lobes using a dissecting
microscope. Histological sections of random lung
samples confirmed the neoplastic nature of the
white deposits being scored as metastases.
Autopsies were done on all mice and any other
apparently abnormal tissue examined histologically.
Heterogeneity ofthe CMT64 cell line
In vitro cloning Single cells selected from a dilute
cell suspension using a 1 pl Pederson pipette, were
transferred to wells of a Titertek plate (Flow
Laboratories, Irvine, Scotland) and clones
established from wells with single colonies.
In vivo selection Four different metastasising
sublines of CMT64; 167, 170, 175 and 181 were
sequentially selected from lung metastases in
C57B/T female mice as follows: Pooled lung
metastases arising from a tumour produced by
CMT64/22 (culture passage no. 22) cells were
transplanted s.c. and mixed fragments from the
resultant s.c. tumour explanted in culture. Epithelial
outgrowths were established as the first subline
CMT167. Five x 106 CMT 167/4 cells were then
inoculated s.c. and after 3 weeks pooled lung
metastases were again transplanted s.c. and the
resultant s.c. tumour explanted as above to give rise
to CMT170. Subline CMT175 was selected from
CMT170, and CMT181 from CMT175 using the
same method.
Results
The "parent" cell line: CMT64
The development and characterisation of the
CMT64 cell line has been described (Franks et al.,
1976). Details of the ultrastructure of CMT64 (and
of "high" metastatic sublines 167, 170, 175 and
181) and of organ distribution of metastases are to
be found in the accompanying paper (Franks &
Layton, 1984).
In vivo behaviour ofthe cell lines
Syngeneic C57B/T old (25 months) and young (5
months) male and female mice were used to assess
the effects of age and sex of the host on the
tumorigenicity of CMT64 cells. Subcutaneous
inoculation of 5 x 105 cells gave palpable tumours
in 47 of 48 mice by 8 days; after 3 weeks the mice
were killed and the s.c. tumours cleanly excised and
weighed. A significant increase in tumorigenicity
was seen in the old mice of both sexes. The median
value of s.c. tumour weights (mg) and range for the
4 groups of 12 mice were: old female: 312.5mg
(250-500); old male: 300.00mg (100-425); young
female: 100.00mg (30-200); young male: 137.5mg
(75-250). A s.c. dose of 104 cells consistently
produces a local tumour, although tumours
occasionally develop from fewer cells but with a
greatly increased latent period. A s.c. dose of
5 x 105 cells produces well-defined local tumours
that have metastasised to the lung by three weeks.
Stability ofthe tumorigenic and metastatic phenotype
The 'parent' CMT64 cell line and the first lung-
metastases-derived subline CMT167 were examined
to assess any change in tumorigenic or metastatic
behaviour that may have occurred in culture. Both
cell lines were compared at "10-passage" intervals
(- 10 weeks in culture) over 40-50 weeks.
Tumorigenicity was assessed by weight of the local
s.c. tumour and spontaneous metastasising
behaviour by the number of surface pulmonary
metastases. In this preliminary experiment only
small numbers of mice were used and data are not
shown as more extensive studies are in progress,
but results obtained suggest that between passages
16-46 CMT64 cells displayed little difference in
metastatic potential or tumorigenicity. At later
passages up to 66 there appears to have been a
significant increase in tumorigenic and metastatic
ability. CMT167 cells, on the other hand, appeared
stable in tumorigenic and metastatic behaviour over
the period studied i.e. passage 6-46 although there
was some indication of an increase in metastatic
potential at later passages. In all experiments
reported here both CMT64 and 167 were used at
relatively early passages, approximately passage 24
for CMT64 and passage 15 for CMT167 to try to
exclude any variation in in vivo behaviour due to in
vitro induced alterations in phenotype.METASTATIC HETEROGENEITY IN LUNG CARCINOMA 417
Metastasising behaviour ofclones ofCMT64 and of
its sublines
Sublines of CMT64-181 derived from single cell
clones were tested for their ability to metastasise.
Mice were injected s.c. with 5 x 105 cells and killed
22-23 days later. The results are shown in Table I.
These results show that all the cell lines had
different cloning efficiencies and contained
subpopulations of cells of varying metastatic
potential, including one subpopulation that appears
to be non-metastatic - CMT170 clone E9*.
Metastasis after subcutaneous inoculation of
CMT64-181
The metastasising behaviour of the parent CMT64
cell line and the sublines CMT167, 170, 175 and
181 were compared after s.c. inoculation of 5 x 105
cells into adult (4-6 months) C57 B/T female, adult
athymic female Nu/Nu mice (approx. 2 months)
and weanling females (3 weeks) of both strains. All
mice were killed after three weeks. The results are
shown in Table TI. Despite variation in the numbers
of metastases between individual mice, the
sequentially selected sublines show much greater
metastatic ability than the parent CMT64 low
metaststic line irrespective of host. There appears to
be an increase in metastatic potential with
sequential selection but the size of the expressed
increase is strongly influenced by the age and
immune status of the host. The cell lines tend to be
more metastatic in syngeneic mice and show
greatest s.c. tumour growth in syngeneic weanlings.
These results show that both cellular and host
factors are involved in determining the expression
of metastatic potential and are discussed later.
"Metastasis" after intravenous inoculation of
CMT64-181
We have used an "experimental metastasis" assay
to compare the ability of CMT64-181 cells to
colonise the lungs after inoculation of 5 x 105 or
5 x 103 cells in 0.1 ml of serum and antibiotic-free
E4 medium into the tail veins of C57B/T female
adult mice. The group receiving 5 x 105 cells quickly
became ill and were killed within 10 days, by which
time pulmonary metastases were too numerous to
be counted (see Franks & Layton, 1984). The
mice receiving 5 x 103 cells were killed 5 weeks later
and the number of pulmonary metastases counted.
The results are shown in Table III and suggest
that the increased potential of the sublines for
"spontaneous metastatic" ability is accompanied by
an increased though different capacity for lung
colonization.
Table I Metastatic behaviour of CMT64-181 and their
clones in syngeneic adult mice
Number of
pulmonary
metastases in
Cell line and individual C57
clones mice Median Range
CMT64 (x 18) 0,0,0,0,2,3,3,3,
4,4,4,5,5,5,5,5,
9,16.
CMT64/
clones:
(cloning
efficiency
=20.83%)
CMT167
CMT167/10
clones:
(cloning
efficiency
=30.33%)
CMT170
CMT170/5
clones:
(cloning
efficiency
= 12.5%)
C1/6 2,2,6,7,8.
C12/5 3,11,12,14,15.
E4/6 0,2,8,8,9.
EIO/4 0,0,2,5,14.
A7/4 7,7,10,14,105.
(x 24) 2,2,5,7,12,16,21,
22,22,24,27,27,
28,28,30,34,34,
61,63,68,77,85,
90,99.
A5/12 10,15,16,19,20.
C2/7 4,5,7,8,14.
C4/12 9,19,31,33,34.
C6/10 19,40,46,50,61.
CIO/14 16,16,64,68.
E1/14 12,18,25,30,37.
E9/9 0,0,1,1,3.
G4/13 3,5,6,9,21.
(x 19) 0,4,4,9,11,11,18,
18,19,33,35,35,
38,43,50,57,61,
84,96.
C1O/8
*E9/9
G12/10
4,5,18,27,53.
0,0,0,0,0.
7,16,20,43,103.
CMT175 (x 10) 8,10,10,16,17,17,
17,21,34,49.
CMT175/7
clones:
(cloning
efficiency
=8.33%)
CMT181
CMT181/7
clones:
(cloning
efficiency
=8.33%)
A5/14 6,9,25,27,47.
El1/12 6,16,16,24,54.
(x 14) 3,4,5,6,8,10,10,
17,21,21,26,28,
40,46.
Al/15 5,5,6,16,18.
A5/9 7,8,14,18,19.
4.0 (0-16)
6.0
12.0
8.0
2.0
10.0
(2-8)
(3-15)
(0-9)
(0-14)
(7-105)
27.5 (2-99)
16.0
7.0
31.0
46.0
40.0
25.0
1.0
6.0
(10-20)
(4-14)
(9-34)
(19-61)
(16-68)
(12-37)
(0-3)
(3-21)
33.0 (0-96)
18.0 (4-53)
0.0 (0-0)
20.0 (7-103)
17.0 (8-49)
25.0 (6-47)
16.0 (6-54)
13.5 (3-46)
6.0 (5-18)
14.0 (7-19)418 M.G. LAYTON & L.M. FRANKS
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Table III Comparison of lung colonization by CMT64-
181 cells after i.v. Inoculation of 5 x 103 cells in C57 adult
mice
Cell line and Number ofpulmonary Median number
passage number deposits (Range)
CMT64/28 0,0,2,2,24 2.0
(0-24)
CMT167/19 2,5,7,9,17 7.0
(2-17)
CMT170/16 13,20,29,32,32 29.0
(13-32)
CMT175/19 6,16,91,99,101 91.0
(6-101)
CMT181/18 9,22,78,166 50.0
(9-166)
Discussion
There is evidence that metastasis is a selective and
not a random process implying the pre-existence of
cell subpopulations of varying metastatic potential
within a primary tumour (Poste & Fidler, 1980;
Talmadge, 1983). We have confirmed this
metastatic cellular heterogeneity since "high"
metastatic sublines have been selected from the
"low" metastatic CMT64 parent line. Other
workers have obtained similar results (e.g. Fidler &
Cifone, 1979; Neri et al., 1982), although Weiss
(Weiss et al., 1983) points out that the
subpopulation hypothesis may not be a general
rule.
Poste et al. (1982) using B16 melanoma cell lines,
have shown that cellular heterogeneity is not
restricted to primary tumours but exists to a more
limited degree in "spontaneous" and
"experimental" metastases.
The uncloned parent line and the sublines
selected from pooled lung metastases used in our
metastasis assays are heterogeneous (see Table I)
and have remained relatively stable since their
initiation. The variation in expressed metastatic
potential between individual mice may thus be due
to variations in host response against different cell
subpopulations. In our experiments the use of
heterogeneous sublines, possibly stabilised by clonal
interactions (Poste et al., 1981), may have been
advantageous, since although phenotypic drift may
occur this instability is often much greater in
clonally derived sublines (Hart & Fidler, 1981). The
existence of metastatic heterogeneity and evidence
for stabilisation of heterogeneous cell populations
by clonal interactions support the use of well
characterised cellular subpopulations with defined
stable metastatic capabilities isolated from the
original heterogeneous tumour cell population
(Hart & Fidler, 1981). It is also essential that
experimental metastasis models reflect as closely as
possible clinical metastatic disease. Unfortunately
many experimental systems do not meet (in
contrast to CMT64 - see conclusion) the basic
requirements of a suitable model. (For a detailed
discussion of these problems, see Hewitt 1976, 1980;
Poste, 1982.)
Another problem associated with choice of
models for metastasis is that many of the tumours
used do not metastasise spontaneously. These
systems depend on the i.v. inoculation of very large
numbers of single tumour cells directly into the
blood stream at one time, 'experimental metastasis';
certainly not representative of the normal
metastatic process in clinical cancer. In the CMT64
system the cells spread in solid cords extending
from the main tumour and dissemination of single
cells is not common. The frequency with which
small numbers of tumour cells are found in the
blood in man without development of metastases
(Malmgren, 1967) and a similar lack of metastases
in patients in whom ascitic fluid containing small
clumps of tumour cells had been diverted into the
blood-lymphatic system (Tarin, personal
communication) together with data showing that
the majority of tumour cells reaching the
circulation do not survive (Weiss et al., 1982) would
seem to make it unlikely that single tumour cells or
even small clumps will produce distant metastases.
Even with highly malignant experimental tumours,
a substantial number of tumour cells must be
inoculated before a tumour will develop, e.g. 104
for CMT64 cells. Our results have shown that the
different metastatic abilities shown by the CMT64-
181 lines after s.c. inoculation are only partially
paralleled by lung colonising ability after i.v.
inoculation and Stackpole (1981) has suggested that
organ colonisation after injection of cells directly
into blood vessels does not necessarily predict
spontaneous metastatic potential from s.c.
transplants, and has reported the existence of two
distinct cell populations in the B16 melanoma: lung
colonizing and lung metastasising.
In our system both cellular and host factors are
involved in determining local tumour growth and
metastasis since the cell lines differ in
tumorigenicity and metastatic capacity depending
on the age and immune status of the host. All cell
lines produced larger tumours in syngeneic
weanlings, and in general were more metastatic in
syngeneic hosts. This was unexpected since we felt
that the immunoincompetence of Nu/Nu mice
might allow greater expression of metastatic
potential, although other workers have suggested
that the nude mouse may be less susceptible to the
development of metastases from murine tumours
(e.g. Skov et al., 1976; Prehn & Lappe, 1971; Fidler
et al., 1977). Our results have shown that Nu/Nu420 M.G. LAYTON & L.M. FRANKS
weanling mice appear to allow greater expression of
the metastatic potential of CMT170, 175 and 181
cell lines than the Nu/Nu adults, and that all cell
lines metastasise to a greater extent in syngeneic
adults than Nu/Nu adult hosts. Hanna (1982) has
reviewed evidence suggesting that an active T cell
independent defence mechanism might be
responsible for the low incidence of tumour
metastasis in adult nude mice and that low natural
killer (NK) cell activity in weanling three week old
mice may support the expression of metastatic
potential.
We have not been able to find any direct
correlation between behaviour in in vitro assays and
metastatic behaviour of the cell lines or their clones
and a preliminary investigation of cell surface
proteins (Steele et al., 1983) has revealed only small
differences between the cell lines although a more
extensive study is in progress. It is thus possible
that the significant differences in metastatic
behaviour may be due, in part, to changes induced
by the host environment.
In conclusion, we feel that the lung tumour
model described here is particularly useful for the
experimental investigation of metastasis, since the
original tumour was spontaneous, is transplantable
to syngeneic immunocompetent hosts and the cell
lines of varying metastatic ability are epithelial,
stable, well differentiated, probably weakly
immunogeneic, metastasise within 3 weeks in both
syngeneic C57B/T and Nu/Nu mice and colonize
the lungs in experimental metastasis assays. The
CMT64 system will be of great value in the study
of the complex cellular and host factors interacting
in the process of metastasis and may be of use in
the screening of therapeutic agents.
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